Oruka Therapeutics (ORKA) Research & Development (2010 - 2024)
Oruka Therapeutics (ORKA) recorded quarterly Research & Development of $130000.0 in Q2 2024, down 21.21% quarter-over-quarter from $165000.0 in Q1 2024, and down 48.82% on a YoY basis from $254000.0 in Q3 2023.
Oruka Therapeutics (ORKA) Research & Development (2010 - 2024) Analysis & Trends
Oruka Therapeutics' Research & Development history runs 15 years deep, the most recent figure standing at $130000.0 for Q2 2024.
- In Q2 2024, Research & Development fell 48.82% year-over-year to $130000.0; the TTM figure through Jun 2024 stood at $664000.0 (down 61.6% YoY), while the FY2023 annual figure was $1.0 million, down 78.67% from the prior year.
- Research & Development was $130000.0 for Q2 2024 at Oruka Therapeutics, down from $165000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $3.9 million in Q4 2021 to a low of $47000.0 in Q4 2023.
- Historically, Research & Development has averaged $1.4 million across 5 years, with a median of $707000.0 in 2022.
- The sharpest annual moves came in 2021 and 2022: Research & Development surged 861.56% in 2021, then plunged 98.45% in 2022.
- A 5-year view of Research & Development shows it stood at $3.2 million in 2020, then advanced by 23.0% to $3.9 million in 2021, then slumped by 98.45% to $61000.0 in 2022, then fell by 22.95% to $47000.0 in 2023, then surged by 176.6% to $130000.0 in 2024.
- The last three Research & Development figures came in at $130000.0 (Q2 2024), $165000.0 (Q1 2024), and $47000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 47,000.00 |
| Sep 30, 2023 | 322,000.00 |
| Jun 30, 2023 | 254,000.00 |
| Mar 31, 2023 | 390,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.44 Mn |
| Jun 30, 2021 | 3.58 Mn |
| Mar 31, 2021 | 2.88 Mn |
| Dec 31, 2020 | 3.20 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | 372,000.00 |
| Mar 31, 2020 | 365,000.00 |
| Dec 31, 2019 | 384,000.00 |
| Sep 30, 2019 | 347,000.00 |